Literature DB >> 14593244

Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation.

Abdullah Kumral1, Hüseyin Baskin, Nuray Duman, Osman Yilmaz, Mansur Tatli, Erdener Ozer, Necati Gökmen, Sermin Genc, Hasan Ozkan.   

Abstract

BACKGROUND: Necrotizing enterocolitis (NEC) is an important neonatal disease with a high mortality rate; erythropoietin (Epo) is a hematopoietic growth factor. Functional Epo receptors are in the fetal and postnatal small bowel and their ligands are available for binding. Excessive nitric oxide (NO) production by an isoform of NO synthase inducible by inflammatory stimuli leads to changes in vascular permeability and tissue injury. The aim of this study was to investigate NO formation in an experimental model of NEC and the possible role of NO in the protection Epo provides against NEC.
METHODS: Twenty-four Wistar albino rat pups were divided into three groups: group 1 = control; group 2 = hypoxia-reoxygenation and saline; group 3 = hypoxia-reoxygenation and recombinant human EPO (rhEpo) pretreatment. rhEpo was given 750 U/kg/week by intraperitoneal injection 3 times a week for 2 weeks. On the 15th day, hypoxia was induced by placing the pups in a 100% CO(2) chamber for 5 min. After the hypoxia period the pups were reoxygenated for 10 min with 100% O(2) and returned to their mothers. All pups were killed 4 h after the hypoxia-reoxygenation period was over. The abdomen was opened and representative samples of injured areas were taken for histopathologic examination. Then nitrite levels were determined in the intestine by Griess Reagent.
RESULTS: On histopathological examination, injury scores in group-2 animals were found to be significantly higher than in group-3 animals (p = 0.001). Significantly increased intestinal nitrite levels were found in group-2 rats compared to the rats of groups 1 and 3 (p = 0.001 and p = 0.001, respectively). There was a positive correlation between the histological findings and the intestinal nitrite levels in group-2 and -3 animals (r = 0.94, p = 0.001; r = 0.99, p = 0.001, respectively).
CONCLUSION: The present study demonstrates that the Epo-pretreated group had decreased levels of NO and limited mucosal necrosis in intestinal tissue samples. We believe that these results deserve further experimental studies in order to elucidate the possible effector mechanisms involved in the inhibitory relationship between Epo, NO and NEC. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593244     DOI: 10.1159/000073642

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  12 in total

1.  The influence of EPO and hypothermia on the kidneys of rats after perinatal asphyxia.

Authors:  Vesna Stojanović; Nada Vučković; Slobodan Spasojević; Nenad Barišić; Aleksandra Doronjski; Dragan Zikić
Journal:  Pediatr Nephrol       Date:  2011-07-02       Impact factor: 3.714

Review 2.  Erythropoietin in stroke therapy: friend or foe.

Authors:  Rhonda Souvenir; Desislava Doycheva; John H Zhang; Jiping Tang
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 3.  Epidemiology of Necrotizing Enterocolitis: New Considerations Regarding the Influence of Red Blood Cell Transfusions and Anemia.

Authors:  Vivek Saroha; Cassandra D Josephson; Ravi Mangal Patel
Journal:  Clin Perinatol       Date:  2018-12-12       Impact factor: 3.430

4.  Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis.

Authors:  Sheng-Ru Shiou; Yueyue Yu; Sangzi Chen; Mae J Ciancio; Elaine O Petrof; Jun Sun; Erika C Claud
Journal:  J Biol Chem       Date:  2011-01-24       Impact factor: 5.157

Review 5.  Cytokines and growth factors in the developing intestine and during necrotizing enterocolitis.

Authors:  Krishnan MohanKumar; Kopperuncholan Namachivayam; Thao T B Ho; Benjamin A Torres; Robin K Ohls; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2016-11-07       Impact factor: 3.300

Review 6.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

Review 7.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

8.  Effectiveness of Saccharomyces boulardii in a rat model of colitis.

Authors:  Mujde Soyturk; Saba Mukaddes Saygili; Huseyin Baskin; Ozgul Sagol; Osman Yilmaz; Fatih Saygili; Hale Akpinar
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

Review 9.  Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?

Authors:  Thomas Coleman; Michael Brines
Journal:  Crit Care       Date:  2004-06-16       Impact factor: 9.097

10.  Erythropoietin protects epithelial cells from excessive autophagy and apoptosis in experimental neonatal necrotizing enterocolitis.

Authors:  Yueyue Yu; Sheng-Ru Shiou; Yuee Guo; Lei Lu; Maria Westerhoff; Jun Sun; Elaine O Petrof; Erika C Claud
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.